MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated
IDR 10,000.00
mbs303 915cdembs303cd20cd3b mbs303t. MBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trials
mbs303, MBS303 | LOGIN MBS303 | DAFTAR MBS303 | LINK MBS303 | SITUS MBS303 | LINK MBS 303 | DAFTAR MBS.
Quantity: